MARKET

RFL

RFL

Rafael Holdings
NYSE
1.070
-0.040
-3.60%
After Hours: 1.070 0 0.00% 16:15 11/13 EST
OPEN
1.070
PREV CLOSE
1.110
HIGH
1.110
LOW
1.030
VOLUME
27.56K
TURNOVER
--
52 WEEK HIGH
3.960
52 WEEK LOW
0.9901
MARKET CAP
55.84M
P/E (TTM)
-1.8557
1D
5D
1M
3M
1Y
5Y
1D
Rafael Holdings, Inc. Submits NDA for Remibetadex Following Phase 3 TransportNPC Study
NASDAQ · 6d ago
Weekly Report: what happened at RFL last week (1102-1106)?
Weekly Report · 6d ago
Weekly Report: what happened at RFL last week (1026-1030)?
Weekly Report · 11/02 09:47
Rafael Holdings Announces NDA Submission for Remibetadex and Reports Fiscal Year 2026 Financial Results
NASDAQ · 10/29 21:01
Rafael Holdings submits New Drug Application to FDA for remibetadex
TipRanks · 10/29 13:17
Rafael Holdings Submits NDA for Lead Rare Disease Drug
TipRanks · 10/29 12:50
Rafael Holdings GAAP EPS of -$0.18, revenue of $0.24M
Seeking Alpha · 10/29 12:13
Rafael Holdings Q4 EPS $(0.18) Up From $(0.28) YoY, Sales $244.000K Down From $350.000K YoY
Benzinga · 10/29 12:13
More
About RFL
Rafael Holdings, Inc. is a biotechnology company that develops pharmaceuticals and holds interests in clinical and early-stage companies that develop pharmaceuticals and medical devices. The Company's segments include Healthcare, Infusion Technology and Real Estate. The Company’s lead candidate is Trappsol Cyclo, which is being evaluated in clinical trials for the potential treatment of Niemann-Pick Disease Type C1 (NPC1), a rare, fatal and progressive genetic disorder. The Healthcare segment comprises equity interests in LipoMedix Pharmaceuticals Ltd., Barer Institute Inc., Cornerstone Pharmaceuticals, Inc., Cyclo, and Rafael Medical Devices, LLC. The Real Estate segment consists of the Company’s real estate holdings, which comprise a portion of one commercial building in Israel. The Infusion Technology segment comprises equity interests in Day Three Labs, Inc. LipoMedix Pharmaceuticals Ltd. is a clinical-stage pharmaceutical company.

Webull offers Rafael Holdings Inc stock information, including NYSE: RFL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RFL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RFL stock methods without spending real money on the virtual paper trading platform.